Aleksandra A Pandyra Selected Research

Hematoxylin (Haematoxylon)

4/2022

Communicator-Driven Data Preprocessing Improves Deep Transfer Learning of Histopathological Prediction of Pancreatic Ductal Adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aleksandra A Pandyra Research Topics

Disease

10	Infections 01/2022 - 02/2013
9	Neoplasms (Cancer) 01/2022 - 07/2007
5	Virus Diseases (Viral Diseases) 01/2019 - 06/2014
3	Melanoma (Melanoma, Malignant) 01/2022 - 01/2020
3	Vesicular Stomatitis 01/2018 - 02/2015
2	Cholestasis 01/2020 - 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022
1	Leukemia 10/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020
1	Multiple Myeloma 10/2020
1	Hematologic Neoplasms (Hematological Malignancy) 10/2020
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 02/2020
1	Intellectual Disability (Idiocy) 01/2020
1	Necrosis 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Hyperglycemia 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2019
1	Arenaviridae Infections 01/2018
1	Inflammation (Inflammations) 01/2018
1	Iron Deficiencies 01/2018
1	Sepsis (Septicemia) 11/2015
1	Breast Neoplasms (Breast Cancer) 09/2015
1	Hyperbilirubinemia 01/2015
1	Liver Diseases (Liver Disease) 01/2015
1	Anemia 01/2015
1	Septic Shock (Toxic Shock Syndrome) 02/2013

Drug/Important Bio-Agent (IBA)

4	Interferon Type IIBA 01/2018 - 05/2015
3	CytokinesIBA 01/2022 - 02/2013
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2007
3	Antiviral Agents (Antivirals)IBA 01/2019 - 06/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2020 - 09/2015
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018 - 11/2015
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2022
1	Hematoxylin (Haematoxylon)IBA 04/2022
1	CaspasesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2020
1	16S Ribosomal RNAIBA 10/2020
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 10/2020
1	Phosphodiesterase InhibitorsIBA 10/2020
1	Cilostazol (Pletal)FDA LinkGeneric 10/2020
1	Adenosine Monophosphate (AMP)IBA 10/2020
1	Dipyridamole (Persantine)FDA LinkGeneric 10/2020
1	Cyclic AMP (AMP, Cyclic)IBA 10/2020
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2020
1	Phosphotransferases (Kinase)IBA 02/2020
1	Antineoplastic Agents (Antineoplastics)IBA 02/2020
1	Serotonin ReceptorsIBA 02/2020
1	Serotonin (5 Hydroxytryptamine)IBA 02/2020
1	VemurafenibIBA 02/2020
1	Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA 02/2020
1	Caspase 3 (Caspase-3)IBA 02/2020
1	cobimetinibIBA 02/2020
1	Caspase 8 (Caspase-8)IBA 02/2020
1	Pharmaceutical PreparationsIBA 02/2020
1	tegaserod (Zelnorm)FDA Link 02/2020
1	GlycogenIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Fragile X Mental Retardation ProteinIBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	AntibodiesIBA 01/2020
1	Etanercept (Enbrel)FDA Link 10/2019
1	AntigensIBA 01/2019
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2018
1	CatecholaminesIBA 01/2018
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2018
1	InterferonsIBA 01/2018
1	LithiumIBA 01/2018
1	LeptinIBA 01/2018
1	MineralocorticoidsIBA 01/2018
1	Phosphates (Orthophosphate)IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	VaccinesIBA 01/2017
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 09/2015
1	Fluvastatin FDA Link 09/2015
1	EnzymesIBA 09/2015
1	Mevalonic Acid (Mevalonate)IBA 09/2015
1	Oxidoreductases (Dehydrogenase)IBA 09/2015
1	SterolsIBA 09/2015
1	B-Cell Activation Factor ReceptorIBA 05/2015
1	Neutralizing AntibodiesIBA 02/2015
1	CEACAM1 ProteinIBA 02/2015
1	BilirubinIBA 01/2015
1	LipopolysaccharidesIBA 02/2013
1	Messenger RNA (mRNA)IBA 07/2007
1	Indicators and Reagents (Reagents)IBA 07/2007
1	Thymidylate SynthaseIBA 07/2007

Therapy/Procedure

4	Immunotherapy 01/2022 - 01/2020
4	Ligation 01/2020 - 01/2015
3	Therapeutics 02/2020 - 07/2007